Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?

被引：0

作者：

NM Kaplan

机构：

[1] University of Texas,

[2] Southwestern Medical Center,undefined

来源：

Journal of Human Hypertension | 2000年 / 14卷

关键词：

angiotensin II; angiotensin-converting enzyme inhibitors; angiotensin II-receptor blockers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.

引用

页码：S87 / S90

共 50 条

[1] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
Kaplan, NM
[J]. JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S87 - S90
[2] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
Benenson, Irina
[J]. JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
[3] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
Kaplan, Norman M.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
[4] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
Verdecchia, Paolo
Angeli, Fabio
Reboldi, Gianpaolo
[J]. JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
[5] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH HYPERTENSION
Sanchez, Andres M. Cordova
Shmorgon, Gary
Olonoff, Danielle A.
Ramm, Matthew
Gualan, Carlos Merino
Chaudhuri, Debanik
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2074 - 2074
[6] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
Lonn E.
[J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
[7] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
Baker, William L.
Coleman, Craig I.
Kluger, Jeffrey
Reinhart, Kurt M.
Talati, Ripple
Quercia, Robert
Phung, Olivia J.
White, C. Michael
[J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (12) : 861 - U6
[8] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension
Ritter, J. M.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[9] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Liu, Chia-Lin
Shau, Wen-Yi
Chang, Chia-Hsuin
Wu, Chi-Shin
Lai, Mei-Shu
[J]. JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
[10] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
Boos, CJ
Lip, GYH
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 890

← 1 2 3 4 5 →